These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35608066)

  • 1. Hepatic RACK1 deletion disturbs lipid and glucose homeostasis independently of insulin resistance.
    Qin W; Zhang T; Ge M; Zhou H; Xu Y; Mu R; Huang C; Liu D; Huang B; Wang Q; Kong Q; Kong Q; Li F; Xiong W
    J Endocrinol; 2022 Sep; 254(3):137-151. PubMed ID: 35608066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
    Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
    Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
    Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis.
    Beaulant A; Dia M; Pillot B; Chauvin MA; Ji-Cao J; Durand C; Bendridi N; Chanon S; Vieille-Marchiset A; Da Silva CC; Patouraux S; Anty R; Iannelli A; Tran A; Gual P; Vidal H; Gomez L; Paillard M; Rieusset J
    J Hepatol; 2022 Sep; 77(3):710-722. PubMed ID: 35358616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids as regulators of hepatic lipid and glucose metabolism.
    Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
    Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity.
    Lopez-Pastor AR; Gomez-Hernandez A; Diaz-Castroverde S; Gonzalez-Aseguinolaza G; Gonzalez-Rodriguez A; Garcia G; Fernandez S; Escribano O; Benito M
    Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30642871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic nitric oxide synthase 1 adaptor protein regulates glucose homeostasis and hepatic insulin sensitivity in obese mice depending on its PDZ binding domain.
    Mu K; Sun Y; Zhao Y; Zhao T; Li Q; Zhang M; Li H; Zhang R; Hu C; Wang C; Jia W
    EBioMedicine; 2019 Sep; 47():352-364. PubMed ID: 31473185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.
    Peyrou M; Bourgoin L; Poher AL; Altirriba J; Maeder C; Caillon A; Fournier M; Montet X; Rohner-Jeanrenaud F; Foti M
    J Hepatol; 2015 Feb; 62(2):421-9. PubMed ID: 25234947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.
    Ungerleider NA; Bonomi LM; Brown ML; Schneyer AL
    Endocrinology; 2013 Jun; 154(6):2025-33. PubMed ID: 23533219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.
    Lian J; Wei E; Wang SP; Quiroga AD; Li L; Di Pardo A; van der Veen J; Sipione S; Mitchell GA; Lehner R
    Hepatology; 2012 Dec; 56(6):2154-62. PubMed ID: 22707181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis.
    Winther-Sørensen M; Galsgaard KD; Santos A; Trammell SAJ; Sulek K; Kuhre RE; Pedersen J; Andersen DB; Hassing AS; Dall M; Treebak JT; Gillum MP; Torekov SS; Windeløv JA; Hunt JE; Kjeldsen SAS; Jepsen SL; Vasilopoulou CG; Knop FK; Ørskov C; Werge MP; Bisgaard HC; Eriksen PL; Vilstrup H; Gluud LL; Holst JJ; Wewer Albrechtsen NJ
    Mol Metab; 2020 Dec; 42():101080. PubMed ID: 32937194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.
    Sheng L; Jena PK; Liu HX; Kalanetra KM; Gonzalez FJ; French SW; Krishnan VV; Mills DA; Wan YY
    Sci Rep; 2017 May; 7(1):1748. PubMed ID: 28496104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.
    Xu JL; Li LY; Wang YQ; Li YQ; Shan M; Sun SZ; Yu Y; Wang B
    J Lipid Res; 2018 Jan; 59(1):35-47. PubMed ID: 29113994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
    Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
    Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bile acid sequestration on hepatic steatosis in obese mice.
    Solís N; Pizarro M; Quintero P; Arab JP; Riquelme A; Padilla O; Carrasco G; Pirola CJ; Sookoian S; Arrese M
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):105-12. PubMed ID: 24378273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional VHL gene deletion causes hypoglycemic death associated with disproportionately increased glucose uptake by hepatocytes through an upregulated IGF-I receptor.
    Kurabayashi A; Kakinuma Y; Morita T; Inoue K; Sato T; Furihata M
    PLoS One; 2013; 8(7):e69139. PubMed ID: 23874892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice.
    Costa DK; Huckestein BR; Edmunds LR; Petersen MC; Nasiri A; Butrico GM; Abulizi A; Harmon DB; Lu C; Mantell BS; Hartman DJ; Camporez JP; O'Doherty RM; Cline GW; Shulman GI; Jurczak MJ
    Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E105-16. PubMed ID: 27166280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.